As federal health officials recommend that the use of the Johnson & Johnson COVID-19 vaccine be put on hold, there are some who received the vaccine who say that the benefits outweigh the risks.

The latest data from the Food and Drug Administration and the Centers for Disease Control and Prevention states that six women between the age of 18-48 have had what is being termed a “rare and severe type of blood clot” after they took the vaccine. The symptoms occurred between six and 13 days after getting the shot.

“It was a little nerve-wracking. But the fact that there were only six cases, I’m not so worried,” says Jennifer Bernhardt, who also received the J&J vaccine.

Bernhardt received the shot a month ago and at age 52, is just outside the age range of the women who experienced clotting.

“I haven’t had any issues, health wise. So I feel confident that nothing will happen with me. But of course, no one knows what the long-term effects will be with these shots,” she says.

Bernhardt did not have a choice of vaccine, but she says that she would still recommend it.

“I was just more interested in getting it as soon as possible and I just so happened I was able to get J&J,” Bernhardt says. “The alternative is possibly getting COVID. So it’s kind of one or the other and I prefer to get the shot.”

Bernhardt says that she will be patient and see what the research reveals.